LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Monday reported a loss of $28.9 million in its third quarter.
The Lexington, Massachusetts-based company said it had a loss of 58 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
The biopharmaceutical company posted revenue of $8,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CNCE">Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE